8-K/A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: October 10, 2008
Period of Report: October 1, 2008
Accession Number: 0000950135-08-006444

View Document ↗ View on SEC.gov ↗